MiMedx rises after Craig-Hallum raises price target on Sanara Deal
What it means
- What to watch: $MDXG got a new price target; the reasoning behind it says more than the number does.
- How the stock is trading: $MDXG -7.69% in the latest session.
- Timing: It dropped mid-session, while New York was open, so the move beside it may already include the market's first reaction.
Where the stock stands
$MDXG last changed hands at $3.60, -7.69% on the session, 55% below its 52-week high of $7.97 and 19% above its low of $3.03 — in the lower part of the range. Over the year it has ranged 163% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $MDXG page.
How much coverage it is getting
This is the only story Wook has logged on $MDXG in the last 30 days — a quiet name that just got a headline. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
Coming up
$MDXG earnings today. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
The $MDXG page has the full chart, the filings and the valuation model behind every figure here. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $MDXG sits from its high, or how this week's coverage stacks up.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Healthcare & Pharma. It reads bullish at medium severity because of “rise” in the wording, with nothing on the bearish side to offset it. It was matched to $MDXG. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on August 27, 2026. $MDXG has moved -20.00% ($4.50 to $3.60). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.